Loading...

FITC anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_FITC_1_110210
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) FITC (top) or rat IgG2b, κ FITC isotype control (bottom) (gated on total viable cells).
  • M1slash70_FITC_1_110210
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) FITC (top) or rat IgG2b, κ FITC isotype control (bottom) (gated on total viable cells).
  • M1slash70_FITC_2_110210
Compare all formats See FITC spectral data
Cat # Size Price Quantity Check Availability Save
101205 50 µg 47 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101206 500 µg 132 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Narusawa M, et al. 2014. Cancer Immunol Res. 2:568. PubMed
  2. Ostapoff K, et al. 2014. Cancer Res. 74:4966. PubMed
  3. Fan X, et al. 2015. Cancer Res. 75:86. PubMed
  4. Wang L, et al. 2020. Front Cell Dev Biol. 0.745138889. PubMed
  5. Moreno-García Á, et al. 2020. Biomolecules. 10:00. PubMed
  6. Xue F, et al. 2020. Int J Biol Sci. 2.105555556. PubMed
  7. Gupta P, Rajan M, Kulkarni S, et al. 2017. Int Immunopharmacol. 10.1016/j.intimp.2017.06.025. PubMed
  8. Haimon Z et al. 2018. Nature immunology. 19(6):636-644 . PubMed
  9. Bijland S, et al. 2019. F1000Res. 8:117. PubMed
  10. Furuhashi K, et al. 2017. Immunology. 151:227. PubMed
  11. Miyatake Y, et al. 2018. J Immunol. 201:3051. PubMed
  12. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  13. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  14. Kiepura A, et al. 2021. Int J Mol Sci. 22:. PubMed
  15. Guo H, et al. 2020. Curr Protoc Immunol. 131:e107. PubMed
  16. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  17. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  18. Schädlich IS, et al. 2022. iScience. 25:104470. PubMed
  19. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  20. Nesseler JP, et al. 2020. Cancers (Basel). 12: . PubMed
  21. Song R, et al. 2022. Immunology. 165:274. PubMed
  22. Li X, et al. 2022. J Clin Invest. 132: . PubMed
  23. He D, et al. 2022. Immunity. 55:159. PubMed
  24. Cautivo KM, et al. 2022. Immunity. 55:254. PubMed
  25. Du Y, et al. 2022. FASEB J. 36:e22248. PubMed
  26. van Dierendonck XAMH, et al. 2022. Proc Natl Acad Sci U S A. 119:e2114739119. PubMed
  27. Martin-Martin I, et al. 2022. Cell Rep. 39:110648. PubMed
  28. Liu X, et al. 2022. Adv Sci (Weinh). 9:e2105650. PubMed
  29. Usui-Ouchi A, et al. 2022. Glia. 70:1762. PubMed
  30. Ocaña-Guzman R, et al. 2022. Cells. 11: . PubMed
  31. Li J, et al. 2022. FASEB J. 36:e22400. PubMed
  32. Dong H, et al. 2022. Proc Natl Acad Sci U S A. 119:e2123247119. PubMed
  33. Liu W, et al. 2022. Biomedicines. 10: . PubMed
  34. Komori R, et al. 2022. Int J Mol Sci. 23: . PubMed
  35. Ostendorf BN, et al. 2022. Nature. 611:346. PubMed
  36. Shen Z, et al. 2022. EBioMedicine. 85:104285. PubMed
  37. Xuan FL, et al. 2022. Front Immunol. 13:1005067. PubMed
  38. Foo CX, et al. 2023. Eur Respir J. 61: . PubMed
  39. Zhang Z, et al. 2022. Integr Cancer Ther. 21:15347354221138534. PubMed
  40. Shang T, et al. 2022. Front Pharmacol. 13:1054176. PubMed
  41. Roy S, et al. 2022. Am J Cancer Res. 12:4977. PubMed
  42. Kraemer AN, et al. 2022. Front Immunol. 13:933191. PubMed
  43. Shi C, et al. 2023. Nat Nanotechnol. 18:86. PubMed
  44. Yu J, et al. 2022. Nat Commun. 13:7903. PubMed
  45. Miró L, et al. 2022. Cancers (Basel). 14: . PubMed
  46. An HW, et al. 2022. Cell Rep. 41:111878. PubMed
  47. Chen L, et al. 2022. Cancer Immunol Immunother. :. PubMed
  48. Chan L, et al. 2022. Cells. 12: . PubMed
  49. Wang L, et al. 2022. Nutrients. 15: . PubMed
  50. Montilla A, et al. 2023. Cell Death Dis. 14:16. PubMed
  51. Yang L, et al. 2023. Acta Pharmacol Sin. :. PubMed
  52. Li Y, et al. 2023. Cell Death Dis. 14:28. PubMed
  53. Freitag K, et al. 2023. Commun Biol. 6:40. PubMed
  54. Schmidt AD, et al. 2023. J Invest Dermatol. :. PubMed
  55. Jiang X, et al. 2023. Cell Discov. 9:7. PubMed
  56. Li B, et al. 2023. Nat Commun. 14:489. PubMed
  57. Schick J, et al. 2023. Elife. 12: . PubMed
  58. Zhu X, et al. 2023. Front Immunol. 14:1114802. PubMed
  59. Zhong CS, et al. 2022. Acta Pharmacol Sin. 43:1324. PubMed
  60. Mecklenburg J, et al. 2022. Brain Behav Immun. 101:246. PubMed
  61. Murotomi K, et al. 2022. Exp Biol Med (Maywood). 247:848. PubMed
  62. Zhao X, et al. 2022. Cell Mol Immunol. 19:540. PubMed
  63. Xin DQ, et al. 2022. Neural Regen Res. 17:2238. PubMed
  64. Friedman D, et al. 2022. J Immunol. 208:1845. PubMed
  65. Tao X, et al. 2022. J Exp Med. 219:. PubMed
  66. Lopez R, et al. 2022. Nat Biotechnol. 40:1360. PubMed
  67. Gaikwad H, et al. 2022. ACS Nano. . PubMed
  68. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  69. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  70. Rybova J, et al. 2022. J Inherit Metab Dis. 45:1175. PubMed
  71. Chen Y, et al. 2022. Am J Cancer Res. 12:5286. PubMed
  72. Pan Y, et al. 2023. Adv Sci (Weinh). 10:e2206792. PubMed
  73. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  74. Wang Y, et al. 2023. EBioMedicine. 90:104480. PubMed
  75. Adzika GK, et al. 2023. Front Immunol. 14:1124649. PubMed
  76. Wang YC, et al. 2023. J Exp Med. 220:. PubMed
  77. Wang JX, et al. 2023. JCI Insight. 8:. PubMed
  78. Yang Y, et al. 2023. Cancers (Basel). 15:. PubMed
  79. Dang YZ, et al. 2023. Neoplasma. 70:123. PubMed
  80. Matsuzawa M, et al. 2023. Nat Commun. 14:1417. PubMed
  81. Latour YL, et al. 2023. Gut Microbes. 15:2192623. PubMed
  82. Dona MSI, et al. 2023. Basic Res Cardiol. 118:11. PubMed
  83. Sun JY, et al. 2023. Sci Adv. 9:eade4110. PubMed
  84. Iguchi A, et al. 2023. iScience. 26:106375. PubMed
  85. Han S, et al. 2023. Int J Mol Sci. 24:. PubMed
  86. Zhu CL, et al. 2023. Int J Biol Sci. 19:1413. PubMed
  87. Thai LM, et al. 2023. iScience. 26:106477. PubMed
  88. Seclì L, et al. 2023. J Immunother Cancer. 11:. PubMed
  89. Banka AL, et al. 2023. Nat Commun. 14:2462. PubMed
  90. Li T, et al. 2023. Nat Commun. 14:2498. PubMed
  91. Qin C, et al. 2023. iScience. 26:106588. PubMed
  92. Ji Y, et al. 2023. Nat Cell Biol. 25:726. PubMed
  93. Xu Y, et al. 2023. J Cancer. 14:1182. PubMed
  94. Feng X, et al. 2023. Nat Commun. 14:3208. PubMed
  95. Zhang Y, et al. 2023. NPJ Regen Med. 8:28. PubMed
  96. Chen SW, et al. 2023. Methods Mol Biol. 2683:53. PubMed
  97. Yang QC, et al. 2023. iScience. 26:106916. PubMed
  98. Mawambo G, et al. 2023. J Neuroinflammation. 20:145. PubMed
  99. Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed
  100. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  101. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  102. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  103. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  104. Belmonte L, et al. 2016. Sci Rep. 6:35813. PubMed
  105. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  106. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  107. Giorgetti E, et al. 2020. Cell Reports. 29(6):1539-1554.e7.. PubMed
  108. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  109. Fu R, et al. 2020. Sci Rep. 10:1455. PubMed
  110. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  111. Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed
  112. Bo Yu et al. 2018. Cell stem cell. 23(2):193-209 . PubMed
  113. Shavit Stein E, et al. 2018. Neural Plast. 2018:7692182. PubMed
  114. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  115. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  116. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  117. Gan C, et al. 2022. Respir Res. 23:32. PubMed
  118. He J, et al. 2022. Front Immunol. 12:760138. PubMed
  119. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  120. Okajima T, et al. 2021. Front Immunol. 12:738041. PubMed
  121. Paschall A, et al. 2015. J Immunol. 194: 2369-2379. PubMed
  122. Su N, Xiong Y 2016. Sci Rep. 6:22658. PubMed
  123. Tu S, et al. 2020. Cellular Signalling. 73:109695. PubMed
  124. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  125. Zhang YS, et al. 2018. Cancer Biol Ther. 19:735. PubMed
  126. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  127. Wu G, et al. 2020. Front Oncol. 10:194. PubMed
  128. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  129. Lin R, et al. 2020. Sci Rep. 10:14397. PubMed
  130. Koning B, et al. 2006. Int Immunol. 1.403472222. PubMed
  131. Kapadia D, et al. 2011. PLoS One. 6:e19376. PubMed
  132. Pandey S, et al. 2020. Cell Syst. 11:495. PubMed
  133. Tuominen S, et al. 2021. Eur J Nucl Med Mol Imaging. 48:1312. PubMed
  134. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
  135. Poli V, et al. 2021. iScience. 24:103256. PubMed
  136. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  137. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  138. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  139. Zhu ZY, et al. 2022. Front Immunol. 12:781087. PubMed
  140. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  141. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  142. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  143. Hu J, et al. 2021. Sci Adv. 7:. PubMed
  144. Chen S, et al. 2022. Cancer Discov. :. PubMed
  145. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  146. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  147. Stahnke S, et al. 2021. Current Biology. 31(10):2051-2064.e8. PubMed
  148. Zhang S, et al. 2021. Cell. 184(8):2151-2166.e16. PubMed
  149. Yousif AS, et al. 2020. Immunity. 54(2):235-246.e5. PubMed
  150. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  151. Zaytseva D, et al. 2018. Physiol Rep. 6:e13812. PubMed
  152. Tong X, et al. 2020. Front Pharmacol. 1.404166667. PubMed
  153. Shang W, et al. 2019. J Diabetes Res. 2019:5641271. PubMed
  154. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  155. Lindborg JA et al. 2017. The Journal of Neuroscience. 37(43):10258-10277 . PubMed
  156. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  157. Duan M, et al. 2022. Cell Commun Signal. 20:60. PubMed
  158. Zhang Q, et al. 2021. Theranostics. 11:8301. PubMed
  159. Li B, et al. 2022. iScience. 25:103772. PubMed
  160. DeMarco JK, et al. 2021. Vaccines (Basel). 9:. PubMed
  161. Guan H, et al. 2012. PLoS One. 7:e35650. PubMed
  162. Caiado F, et al. 2013. Cancer Res. 73:4233. PubMed
  163. Lin T, et al. 2015. PLoS One. 10: e0138335. PubMed
  164. Esmaili S, et al. 2021. Cell Systems. 12(5):432-445.e7. PubMed
  165. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  166. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  167. Siew JJ, et al. 2019. Nat Commun. 10:3473. PubMed
  168. Verma M, et al. 2018. Brain Behav Immun. 69:223. PubMed
  169. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  170. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  171. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  172. Yang C, et al. 2020. J Control Release. 326:324. PubMed
  173. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  174. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  175. Tanner MA, et al. 2021. Am J Physiol Heart Circ Physiol. 321:H633. PubMed
  176. Kasper M, et al. 2021. Elife. 10:. PubMed
  177. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
  178. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  179. Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed
  180. Ostendorf BN, et al. 2020. Nat Med. 26:1048. PubMed
  181. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  182. Periasamy S, et al. 2011. J Leukoc Biol. 90:493. PubMed
  183. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
  184. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  185. Luo W, et al. 2019. Mol Med Rep. 20:1007. PubMed
  186. Mayers S, et al. 2019. BMC Biotechnol. 19:21. PubMed
  187. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  188. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  189. Kan C, et al. 2022. Bone Res. 10:62. PubMed
  190. Zhang J, et al. 2021. J Leukoc Biol. 110:485. PubMed
  191. Qiu F, et al. 2022. J Cancer. 13:2893. PubMed
  192. Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed
  193. Hou H, et al. 2021. Front Cell Dev Biol. 9:737003. PubMed
  194. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  195. Liang P, et al. 2022. Mol Biomed. 3:14. PubMed
  196. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  197. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  198. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  199. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  200. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  201. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  202. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  203. Zong Z, et al. 2019. Front Immunol. 10:1643. PubMed
  204. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  205. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  206. Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed
  207. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  208. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  209. Yao L, et al. 2021. J Bone Miner Res. 36:1159. PubMed
  210. Shen Y, et al. 2022. CNS Neurosci Ther. 28:46. PubMed
  211. Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed
  212. Geng T, et al. 2022. Methods Mol Biol. 2585:71. PubMed
  213. Marks KE, et al. 2021. Cell Reports. 35(13):109303. PubMed
  214. Ohgomori T, et al. 2020. Neuropharmacology. 176:108227. PubMed
  215. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  216. Köchl R, et al. 2020. Elife. 9:00. PubMed
  217. Lin D, et al. 2015. Proc Natl Acad Sci U S A. 112: 11324-11329. PubMed
  218. Madan-Lala R, et al. 2014. J Immunol. 192:4263. PubMed
  219. Ippolito G, et al. 2014. Proc Natl Acad Sci U S A. 111:998. PubMed
  220. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  221. Perez–Zsolt D, et al. 2019. Front Immunol. 0.989583333. PubMed
  222. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  223. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  224. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  225. Ye Z, et al. 2019. Mediators Inflamm. 2019:8709583. PubMed
  226. Yuan F, et al. 2022. Front Immunol. 13:798583. PubMed
  227. Forbester JL, et al. 2020. J Virol. 94:. PubMed
  228. Wu H, et al. 2022. Biomolecules. 12:. PubMed
  229. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  230. Gao H, et al. 2021. Cells. 10:. PubMed
  231. Saitoh BY, et al. 2021. Brain Behav Immun. 95:362. PubMed
  232. Tan A, et al. 2012. Mol Pharmacol. 9:2710. PubMed
  233. Cappello P, et al. 2013. Gastroenterology. 144:1098. PubMed
  234. Meraz I, et al. 2014. PLoS One. 9:94703. PubMed
  235. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  236. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  237. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  238. Koivisto CS, et al. 2020. Neoplasia. 1.252777778. PubMed
  239. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  240. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  241. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  242. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  243. Knolle MD et al. 2018. Frontiers in immunology. 1.925 . PubMed
  244. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  245. Wang F, et al. 2018. Carcinogenesis. 39:889. PubMed
  246. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  247. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  248. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  249. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  250. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  251. Yee PP, et al. 2020. Nat Commun. 4.225. PubMed
  252. Dong S, et al. 2021. Nature. 591:117. PubMed
  253. Dang Y, et al. 2021. J Cancer. 12:7158. PubMed
  254. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  255. Yadav P, et al. 2021. J Immunol. 206:2888. PubMed
  256. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  257. Cho YK, et al. 2022. Nat Commun. 13:4084. PubMed
  258. Bao C, et al. 2021. Infect Immun. 89:. PubMed
  259. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  260. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  261. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  262. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  263. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  264. Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
  265. Wang Q, et al. 2018. Nat Commun. 9:559. PubMed
  266. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  267. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  268. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  269. Shiraki N, et al. 2022. Stem Cell Reports. 17:221. PubMed
  270. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  271. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  272. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  273. Miller S, et al. 2016. Acta Biochim Biophys Sin. 48: 334-341. PubMed
  274. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  275. Riedelberger M, et al. 2020. Bio Protoc. e3552:10. PubMed
  276. Endoh M, et al. 2020. Cell Reports. 30(6):1823-1834. PubMed
  277. Cho K, et al. 2021. iScience. 24:103117. PubMed
  278. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  279. Bakker W, et al. 2021. Int J Mol Sci. 22:. PubMed
  280. Li H, et al. 2021. Nat Commun. 12:7149. PubMed
  281. Shan C, et al. 2021. Front Immunol. 12:766401. PubMed
  282. Sobecki M, et al. 2021. Nat Commun. 12:4700. PubMed
  283. Nishida J, et al. 2022. STAR Protoc. 3:101306. PubMed
  284. Lei J, et al. 2021. Theranostics. 4251:11. PubMed
  285. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  286. Chen X, et al. 2016. PLoS One. 11:e0168861. PubMed
  287. Uto T, et al. 2016. Nat Commun. 7: 11273. PubMed
  288. Leon-Rico D, et al. 2015. Lab Anim. 49:132. PubMed
  289. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  290. Simões FC, et al. 2020. Nat Commun. 0.875. PubMed
  291. Ku AT et al. 2017. eLife. 6 pii: e23242. PubMed
  292. Dong L, et al. 2022. Cells. 11:. PubMed
  293. Li Y, et al. 2022. Front Cardiovasc Med. 9:830781. PubMed
  294. Tang C, et al. 2021. Theranostics. 11:9791. PubMed
  295. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  296. Gopinath A, et al. 2022. NPJ Parkinsons Dis. 8:72. PubMed
  297. Sun S, et al. 2021. Front Immunol. 12:777665. PubMed
  298. Ding X, et al. 2015. J Immunol. 194:4251. PubMed
  299. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  300. Takesue S, et al. 2020. Int J Oncol. 56:596. PubMed
  301. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  302. Penkert RR, et al. 2020. Obesity (Silver Spring). 1631:28. PubMed
  303. Jäger M, et al. 2018. Antioxid Redox Signal. 30. PubMed
  304. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  305. Liu D, et al. 2020. Front Pharmacol. 11:204. PubMed
  306. Merlo LM, et al. 2020. Clin Pathol. 13:2632010X20951812. PubMed
  307. Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed
  308. Taddio MF, et al. 2021. Mol Imaging Biol. 23:196. PubMed
  309. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  310. Liu P, et al. 2022. iScience. 25:103867. PubMed
  311. Vasudevan SO, et al. 2022. Cell Rep. 39:110755. PubMed
  312. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  313. Niemi JP, et al. 2020. Methods Mol Biol. 2143:207. PubMed
  314. Dionisio-Santos DA, et al. 2021. Front Neurosci. 15:758677. PubMed
  315. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  316. Dong R, et al. 2021. Frontiers in Immunology. 12:620238. PubMed
  317. Chen S, et al. 2020. Allergy Asthma Immunol Res. 0.922222222. PubMed
  318. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  319. Chen F, et al. 2016. J Immunol. 196: 4390 - 4399. PubMed
  320. Zhuo Y, et al. 2018. Oncol Rep. 40:2147. PubMed
  321. Ponzetta A, et al. 2020. Cell. 178(2):346-360.e24.. PubMed
  322. Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed
  323. Lima-Junior D, et al. 2017. J Immunol. 10.4049/jimmunol.1700258. PubMed
  324. Stevenson ER, et al. 2022. J Pharmacol Exp Ther. 382:356. PubMed
  325. Chen Y, et al. 2022. Life Sci. 306:120826. PubMed
  326. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  327. Ostapoff K, et al. 2013. Mol Cancer Ther. 12:1190. PubMed
  328. Macagno M, et al. 2014. J Immunol. 192:5434. PubMed
  329. Chou H, et al. 2015. Proc Natl Acad Sci U S A. 112:2175. PubMed
  330. Quan S, et al. 2015. J Immunol. 194:4175. PubMed
  331. Richardson ET, et al. 2015. PLoS One. 10: 1371. PubMed
  332. Yamamuro T, et al. 2020. Nat Commun. 3.340277778. PubMed
  333. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  334. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  335. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  336. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  337. Ohgomori T et al. 2019. J Comp Neurol. 528(1):14-31 . PubMed
  338. Li S, et al. 2019. Front Neurol. 1.036805556. PubMed
  339. He S, et al. 2021. Front Pharmacol. 12:743837. PubMed
  340. Hua X, et al. 2021. Front Immunol. 12:706027. PubMed
  341. Feng L, et al. 2022. Signal Transduct Target Ther. 7:21. PubMed
  342. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  343. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  344. Li K, et al. 2020. J Cell Mol Med. 24:13115. PubMed
  345. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  346. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  347. Nasser H, et al. 2020. Cell Death Discov. 0.29375. PubMed
  348. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  349. Kitamura K, et al. 2019. Int J Cardiol Heart Vasc. 23:100344. PubMed
  350. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  351. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  352. Alter C et al. 2019. Am J Physiol Heart Circ Physiol. 317(1):H190-H200 . PubMed
  353. Spolski R et al. 2019. Elife. 8 pii: e45501. PubMed
  354. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  355. Li Q, et al. 2022. Front Oncol. 12:841977. PubMed
  356. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  357. Zhang GL, et al. 2020. Matrix Biol. 93:25. PubMed
  358. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  359. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  360. Mihalik NE, et al. 2021. AAPS PharmSciTech. 22:191. PubMed
  361. Li Y, et al. 2022. STAR Protoc. 3:101364. PubMed
  362. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  363. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  364. Erin N, et al. 2015. Brain Behav Immun. 48: 174-185. PubMed
  365. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
  366. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  367. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  368. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  369. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  370. Glodde N et al. 2017. Immunity. 47(4):789-802 . PubMed
  371. Fox D, et al. 2020. Nat Commun. 0.986111111. PubMed
  372. Deng M, et al. 2019. J Exp Med. 216:2838. PubMed
  373. Chan JY, et al. 2019. Diabetologia. 62:993. PubMed
  374. Adzika GK, et al. 2021. Front Cell Dev Biol. 9:719351. PubMed
  375. Tang S, et al. 2022. Virol J. 19:32. PubMed
  376. Cui Y, et al. 2022. Front Oncol. 12:732860. PubMed
  377. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  378. Tähtinen S, et al. 2022. Nat Immunol. 23:532. PubMed
  379. Patel C, et al. 2022. Curr Protoc. 2:e400. PubMed
  380. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  381. Liu SS, et al. 2021. Immunity. :. PubMed
  382. Zhou JH, et al. 2020. Onco Targets Ther. 7.278472222. PubMed
  383. Sitapara RA, et al. 2020. Mol Med. 26:63. PubMed
  384. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  385. Zhong B, et al. 2013. Sci Signal. 6:35. PubMed
  386. Woods B, et al. 2019. Clin Cancer Res. 25:5901. PubMed
  387. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  388. Calvente CJ, et al. 2019. J Clin Invest. 130:4091. PubMed
  389. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  390. Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed
  391. Uehara M, et al. 2019. Sci Rep. 9:6535. PubMed
  392. Wang Y, et al. 2022. Nat Commun. 13:1454. PubMed
  393. Zhang XL, et al. 2022. J Am Heart Assoc. 11:e023800. PubMed
  394. Wang X, et al. 2022. Elife. 11:. PubMed
  395. Adzika GK, et al. 2021. Front Cardiovasc Med. 8:719805. PubMed
  396. Chen X, et al. 2021. Cell Death Dis. 12:1123. PubMed
  397. Chen J, et al. 2021. Oncol Lett. 21:409. PubMed
  398. Hegde V, et al. 2015. J Immunol. 194:5211. PubMed
  399. Chen MB, et al. 2020. Cell Rep. 30:4418. PubMed
  400. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  401. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  402. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  403. Bartley A, et al. 2018. Front Physiol. 9:1593. PubMed
  404. Geng S, et al. 2019. Sci Adv. 5:eaav2309. PubMed
  405. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  406. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  407. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  408. Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
  409. Luo ZW, et al. 2021. Int J Nanomedicine. 16:2949. PubMed
  410. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  411. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  412. Shin SH, et al. 2022. Clin Exp Otorhinolaryngol. . PubMed
  413. Palma A, et al. 2022. Front Cell Dev Biol. 10:841548. PubMed
  414. Jia J, et al. 2022. Nat Commun. 13:6804. PubMed
  415. Dai B, et al. 2021. Cell Reports Medicine. 2(8):100381. PubMed
  416. Trivedi S, et al. 2020. Elife. 9:00. PubMed
  417. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  418. Koronyo Y, et al. 2015. Brain. 138: 2399-2422. PubMed
  419. Zhao Y, et al. 2013. J Leukoc Biol. 94:1103. PubMed
  420. Ribechini E, et al. 2017. Blood Adv. 0.699305556. PubMed
  421. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  422. Moriyasu T, et al. 2018. PLoS Negl Trop Dis. 12:e0006197. PubMed
  423. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  424. Wang S, et al. 2022. Blood. 140:171. PubMed
  425. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  426. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  427. Wu KKL, et al. 2021. Nat Commun. 12:6637. PubMed
  428. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  429. Xue Y, et al. 2020. Sci Rep. 10:22265. PubMed
RRID
AB_312788 (BioLegend Cat. No. 101205)
AB_312789 (BioLegend Cat. No. 101206)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
Specificity (DOES NOT SHOW ON TDS):
CD11b
Specificity Alt (DOES NOT SHOW ON TDS):
CD11b
App Abbreviation (DOES NOT SHOW ON TDS):
FC
UniProt
View information about CD11b on UniProt.org

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
KIRAVIA Blue 520™ anti-mouse/human CD11b M1/70 FC
PE/Fire™ 744 anti-mouse/human CD11b M1/70 FC
Spark PLUS UV™ 395 anti-mouse/human CD11b M1/70 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account